SelectQuote - SLQT Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 32.89%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.01
▲ +0.12 (4.15%)

This chart shows the closing price for SLQT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New SelectQuote Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SLQT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SLQT

Analyst Price Target is $4.00
▲ +32.89% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for SelectQuote in the last 3 months. The average price target is $4.00, with a high forecast of $5.00 and a low forecast of $3.00. The average price target represents a 32.89% upside from the last price of $3.01.

This chart shows the closing price for SLQT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 2 polled investment analysts is to moderate buy stock in SelectQuote. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/29/2024Noble FinancialInitiated CoverageOutperform$5.00Low
9/14/2023Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$3.00Low
2/22/2023Credit Suisse GroupBoost TargetNeutral$1.00 ➝ $3.00Low
2/8/2023CitigroupBoost TargetNeutral$0.80 ➝ $1.50Low
11/24/2022Credit Suisse GroupSet Target$1.00Low
8/30/2022Royal Bank of CanadaLower TargetSector Perform$3.00 ➝ $2.00Low
8/30/2022CitigroupLower TargetNeutral$2.75 ➝ $1.50Low
5/5/2022Piper SandlerLower Target$4.00 ➝ $3.00Medium
2/8/2022BarclaysLower TargetEqual Weight$9.00 ➝ $5.00High
2/8/2022Royal Bank of CanadaLower TargetSector Perform$13.00 ➝ $3.00High
2/8/2022Piper SandlerDowngradeOverweight ➝ Neutral$20.00 ➝ $4.00High
2/8/2022CitigroupDowngradeBuy ➝ Neutral$14.00 ➝ $4.00High
2/8/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$14.00 ➝ $4.00High
1/18/2022BarclaysDowngradeOverweight ➝ Equal Weight$21.00 ➝ $9.00High
11/18/2021Jefferies Financial GroupInitiated CoverageHold$12.00High
9/15/2021CitigroupLower TargetBuy$34.00 ➝ $20.00Low
8/27/2021Morgan StanleyLower TargetEqual Weight$27.00 ➝ $16.00High
8/26/2021Piper SandlerLower TargetOverweight ➝ Overweight$39.00 ➝ $20.00High
8/26/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$33.00 ➝ $13.00High
8/26/2021Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$30.00 ➝ $13.50High
3/25/2021The Goldman Sachs GroupInitiated CoverageBuy$36.00High
2/10/2021CitigroupBoost Target$32.00 ➝ $34.00Low
2/9/2021Credit Suisse GroupBoost TargetOutperform$31.00 ➝ $35.00Low
2/9/2021Morgan StanleyBoost TargetEqual Weight$25.00 ➝ $27.00Low
2/9/2021Evercore ISIBoost TargetOutperform$35.00 ➝ $38.00Low
2/9/2021BarclaysBoost TargetOverweight$32.00 ➝ $36.00Low
1/15/2021Morgan StanleyBoost TargetEqual Weight$24.00 ➝ $25.00Low
11/9/2020Morgan StanleyLower TargetEqual Weight$27.00 ➝ $24.00High
9/10/2020Morgan StanleyLower TargetEqual Weight$29.00 ➝ $27.00High
9/8/2020Credit Suisse GroupLower TargetOutperform$38.00 ➝ $31.00Low
6/15/2020Morgan StanleyInitiated CoverageEqual Weight$29.00High
6/15/2020BarclaysInitiated CoverageOverweight$32.00High
6/15/2020CitigroupInitiated CoverageBuy$32.00High
6/15/2020Credit Suisse GroupInitiated CoverageOutperformHigh
6/15/2020Royal Bank of CanadaInitiated CoverageOutperform$32.00High
6/15/2020Evercore ISIInitiated CoverageOutperform$32.00High
6/15/2020Keefe, Bruyette & WoodsInitiated CoverageOutperform$32.00High
6/15/2020Jefferies Financial GroupInitiated CoverageHold$29.00High
6/15/2020Piper SandlerInitiated CoverageOverweight$32.00High
6/15/2020Cantor FitzgeraldInitiated CoverageOverweight$32.00High
(Data available from 5/25/2019 forward)

News Sentiment Rating

0.10 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2023
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
11/27/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/26/2024
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2024
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2024
  • 1 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
5/25/2024

Current Sentiment

  • 1 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
SelectQuote logo
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies. The company also provides SelectRx, an accredited patient-centered pharmacy home pharmacy, which offers essential prescription medications, OTC medications, customized medication packaging, medication therapy management, and long-term pharmacy care; and population health that helps members understand the benefits available under their health plans, and contracts with insurance carriers. SelectQuote, Inc. was incorporated in 1999 and is headquartered in Overland Park, Kansas.
Read More

Today's Range

Now: $3.01
Low: $2.87
High: $3.03

50 Day Range

MA: $2.07
Low: $1.51
High: $3.05

52 Week Range

Now: $3.01
Low: $1.03
High: $3.13

Volume

648,650 shs

Average Volume

1,004,093 shs

Market Capitalization

$509.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Frequently Asked Questions

What sell-side analysts currently cover shares of SelectQuote?

The following equities research analysts have issued stock ratings on SelectQuote in the last year: Noble Financial, and Royal Bank of Canada.
View the latest analyst ratings for SLQT.

What is the current price target for SelectQuote?

2 Wall Street analysts have set twelve-month price targets for SelectQuote in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 32.9%. Noble Financial has the highest price target set, predicting SLQT will reach $5.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $3.00 for SelectQuote in the next year.
View the latest price targets for SLQT.

What is the current consensus analyst rating for SelectQuote?

SelectQuote currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for SLQT.

What other companies compete with SelectQuote?

Other companies that are similar to SelectQuote include Waterdrop, Roadzen, GoHealth, Fanhua and eHealth. Learn More about companies similar to SelectQuote.

How do I contact SelectQuote's investor relations team?

SelectQuote's physical mailing address is 6800 WEST 115TH STREET SUITE 2511, OVERLAND PARK KS, 66211. The company's listed phone number is 913-599-9225 and its investor relations email address is [email protected]. The official website for SelectQuote is www.selectquote.com. Learn More about contacing SelectQuote investor relations.